KB
Kruse Bo
Chief Financial Officer
C-suiteM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Kruse Bo, Chief Financial Officer. Officer active across 1 company, notably Y-mAbs Therapeutics, Inc.. Aggregated, 22 disclosures have been recorded. Split: 0 buy · 19 sells. Total volume traded: €1.6m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 30 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kruse Bo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
28,629 shares@ US$2.001.6% of flowCommon StockSEC:0001104659-24-067356:0
18,100 shares0Common StockSEC:0001415889-24-001644:0
11,700 shares0Common StockSEC:0001104659-23-005026:0
4,000 shares@ US$7.851.7% of flowCommon StockSEC:0001104659-22-026182:0
4,000 shares@ US$7.971.7% of flowCommon StockSEC:0001104659-22-012870:0
4,000 shares@ US$9.842.1% of flowCommon StockSEC:0001104659-22-007441:0
4,000 shares@ US$17.123.6% of flowCommon StockSEC:0001104659-22-001565:0
4,000 shares@ US$16.363.5% of flowCommon StockSEC:0001104659-21-153184:0
4,000 shares@ US$16.353.5% of flowCommon StockSEC:0001104659-21-147273:0
4,000 shares@ US$18.093.8% of flowCommon StockSEC:0001104659-21-143090:0
4,000 shares@ US$27.545.7% of flowCommon StockSEC:0001104659-21-135122:0
4,000 shares@ US$25.945.3% of flowCommon StockSEC:0001104659-21-130079:0
4,000 shares@ US$28.785.9% of flowCommon StockSEC:0001104659-21-123198:0
4,000 shares@ US$30.826.3% of flowCommon StockSEC:0001104659-21-118852:0
4,000 shares@ US$32.036.5% of flowCommon StockSEC:0001104659-21-113880:0
4,000 shares@ US$28.605.8% of flowCommon StockSEC:0001104659-21-109000:0
4,000 shares@ US$33.726.8% of flowCommon StockSEC:0001104659-21-100844:0
4,000 shares@ US$34.507.0% of flowCommon StockSEC:0001104659-21-095581:0
4,000 shares@ US$34.156.9% of flowCommon StockSEC:0001104659-21-089877:0
4,000 shares@ US$36.177.2% of flowCommon StockSEC:0001104659-21-084646:0
4,000 shares@ US$33.486.6% of flowCommon StockSEC:0001104659-21-077698:0
4,000 shares@ US$35.617.0% of flowCommon StockSEC:0001104659-21-072451:0
About Kruse Bo
Kruse Bo is Chief Financial Officer at Y-MAbs Therapeutics, Inc., where the listed function is EVP, CFO, SECRY & TREAS. A total of 22 filings are recorded, and the sampled recent filings from 2021-05-26 to 2024-05-31 show only sales, with a total amount of EUR 1620055.
